Gallacher Capital Management LLC Buys 79 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Gallacher Capital Management LLC lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,679 shares of the company’s stock after purchasing an additional 79 shares during the period. Gallacher Capital Management LLC’s holdings in HCA Healthcare were worth $504,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in HCA. Corient Private Wealth LLC lifted its position in shares of HCA Healthcare by 1.0% during the 4th quarter. Corient Private Wealth LLC now owns 39,067 shares of the company’s stock worth $11,724,000 after buying an additional 381 shares in the last quarter. Envestnet Portfolio Solutions Inc. boosted its position in HCA Healthcare by 14.7% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 15,623 shares of the company’s stock worth $4,689,000 after purchasing an additional 2,002 shares during the last quarter. Tidemark LLC purchased a new position in shares of HCA Healthcare in the 4th quarter worth about $36,000. First Eagle Investment Management LLC boosted its holdings in shares of HCA Healthcare by 0.5% in the 4th quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock worth $1,351,830,000 after buying an additional 23,177 shares during the last quarter. Finally, Carret Asset Management LLC boosted its stake in HCA Healthcare by 8.0% in the fourth quarter. Carret Asset Management LLC now owns 11,970 shares of the company’s stock valued at $3,593,000 after acquiring an additional 883 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. Barclays dropped their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. Morgan Stanley dropped their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Finally, Royal Bank of Canada dropped their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Trading Up 1.6 %

Shares of HCA opened at $319.82 on Friday. The firm’s 50 day simple moving average is $319.00 and its 200 day simple moving average is $345.26. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market capitalization of $78.74 billion, a P/E ratio of 14.56, a P/E/G ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the company earned $5.90 earnings per share. Sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. HCA Healthcare’s payout ratio is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.